Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001213900-25-043722
Filing Date
2025-05-15
Accepted
2025-05-15 08:32:06
Documents
2

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 15280
2 JOINT FILING STATEMENT ea024202803ex99-1_vivo.htm EX-99.1 5999
  Complete submission text file 0001213900-25-043722.txt   23063
Mailing Address 3RD FLOOR, 1 ASHLEY ROAD ALTRINCHAM CHESIRE X0 WA14 2DT
Business Address 3RD FLOOR, 1 ASHLEY ROAD ALTRINCHAM CHESIRE X0 WA14 2DT 1-716-676-6461
COMPASS Pathways plc (Subject) CIK: 0001816590 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-92194 | Film No.: 25948930
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 192 LYTTON AVENUE PALO ALTO CA 94301
Business Address 192 LYTTON AVENUE PALO ALTO CA 94301 6506880818
Vivo Opportunity Fund Holdings, L.P. (Filed by) CIK: 0001930214 (see all company filings)

EIN.: 873802421 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A